This issue describes Russian commercial pharmacy market in March 2007.
Drugs commercial market value in pharmacy purchase prices increased by 9.8% in March compared to February 2007 and amounted to $477 mln (VAT included); thus, 1st quarter 2007 capacity amounted to about $1.3 billion which is 16.5% higher than that of 2006.
The weighted average price per drug unit on Russian commercial market almost did not increase and amounted to 40 rubles ($1.53) in March 2007.
According to Laspeyres index prices increased by 1.2% in rubles in comparison to February 2007; and by 2.1% in dollars. For the TOP-100 leading brands of 2006, prices increased in March 2007 by 0.7% in rubles and by 1.6% in dollars.
Drugs consumption structure almost did not changed in March 2007 compared to February 2007. The highest increase (+19%) was observed for the expensive drugs priced 500 rubles and more per unit. In March 2007 the weighted average cost per unit was the same as in February 2007 for all price segments.
In the 1st quarter 2007, domestic drugs share stayed the same as the year before and amounted to 25% of the commercial market. Domestic drugs share decreased by 3% in the 1st quarter 2007 and amounted to 66%.
In the 1st quarter 2007, proportion of Rx and OTC drugs stayed the same as the year before. Rx drugs cover 56% of commercial sales value. At that, in the 1st quarter 2007 Rx drugs share increased by 2% in units compared to hat of 2006, and amounted to 36%.
TOP-3 drugs manufactures of February 2007 saved their positions in March as well. The leading Pharmstandard company’s share increased by 0.18%. Sanofi-Aventis and Berlin-Chemie /A.Menarini/ stayed at the 2nd and the 3rd positions despite of their slight sales decrease.
In March 2007, Arbidol (2.1% market share) saved its leading position in TOP drug trade names; however it slightly increased its share. Anticatarrhal medications sales decreased due to the end of winter period. Theraflu (0.89%) stayed in March on the 2nd position in rating, however its sales decreased by 14%. Polivitamin Vitrum (0.85%) is the 3rd one.
In March 2007 Russian NS (nutritional supplements) pharmacy market value increased by 17.6% compared to February 2007 and amounted to $23.3 mln. Thus, the 1st quarter 2007 increased by 5% compared to hat of 2006. Besides, NS market volume increased by 7% and amounted to 17 mln units.
The weighted average cost per NS unit highly increased in March 2007 (+10%) and amounted to $1.88 (49 rubles).
All market reviews by DSM Group are available on the page Analytics.
